Medicaid Breast Cancer Access to Treatment Act
- Sponsor
- Rep. Waters, Maxine [D-CA-43]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Jul 17, 2025
Bottom line
The bill mandates nationwide Medicaid coverage for breast and cervical cancer treatment and breast reconstruction, ensuring consistent access to care for eligible individuals.
What it actually does
This bill amends the Social Security Act to make Medicaid coverage for certain individuals with breast or cervical cancer mandatory for all states, rather than optional. It also explicitly includes breast reconstruction following a medically necessary mastectomy as a required Medicaid benefit. The changes would take effect one year after enactment.
Proponents argue
Proponents argue that this legislation will eliminate disparities in access to life-saving cancer treatment and crucial post-mastectomy care by ensuring all states provide these essential Medicaid benefits. They contend it will improve health outcomes for vulnerable populations and reduce the financial burden on individuals battling cancer.
Opponents contend
Opponents, particularly those focused on fiscal conservatism or states' rights, may argue that mandating additional Medicaid benefits imposes an unfunded or underfunded burden on states, potentially straining state budgets. They might contend that states should retain the flexibility to determine their own Medicaid benefit packages based on local needs and fiscal capacity.
The bill text is very short and clear, making it highly accessible for a reader to understand its core provisions within a few minutes.
Section 2(a)
Mandatory Medicaid Coverage for Breast and Cervical Cancer Patients
This provision amends Section 1902(a)(10) of the Social Security Act to require all state Medicaid programs to cover certain individuals with breast or cervical cancer. Previously, states had the option to cover these individuals under subclause (XVIII); this bill removes that optionality and makes it a mandatory coverage group under a new subclause (X). This ensures that eligible individuals across all states will receive Medicaid coverage for their cancer treatment.
Supporters argue
Supporters argue that making this coverage mandatory ensures equitable access to critical cancer treatment for all eligible individuals, regardless of their state of residence, thereby reducing health disparities and improving public health outcomes.
Critics contend
Critics may argue that this provision represents federal overreach, imposing additional financial burdens and reducing programmatic flexibility for states, particularly those that currently do not offer this optional coverage.
Tradeoffs
The provision balances the goal of universal access to essential healthcare services with concerns about state autonomy and fiscal responsibility. It ensures a baseline of care but at the cost of state-level discretion.
Section 2(b)
Inclusion of Breast Reconstruction as Medical Assistance
This provision amends Section 1905(a) of the Social Security Act to explicitly include "breast reconstruction following a medically necessary mastectomy" as a covered medical assistance service under Medicaid. This means that states will be required to provide coverage for reconstructive surgery after a mastectomy, recognizing it as an integral part of comprehensive cancer care.
Section 2(c)
Conforming Amendments for FMAP and Cost Sharing
This section makes necessary technical adjustments to other parts of the Social Security Act to align with the new mandatory coverage. Specifically, it updates references in the Federal Medical Assistance Percentage (FMAP) calculations and cost-sharing provisions to reflect the new subclause (X) for breast/cervical cancer patients. These amendments ensure that the federal matching funds and rules regarding patient cost-sharing are correctly applied to the newly mandated coverage group.
Section 2(d)
Effective Date
This provision stipulates that the amendments made by the Act will apply beginning one year after the date of its enactment. This delayed effective date provides states and federal agencies with a transition period to implement the new mandatory coverage requirements, update their systems, and adjust their budgets accordingly.
Amends subsection (aa) of Section 1902 by inserting 'as in effect on the day before the date of the enactment of the Patient Protection and Affordable Care Act,' after '(42 U.S.C. 300gg(c)),'. This clarifies the definition of 'certain breast or cervical cancer patients' by referencing the federal definition of medical assistance as it existed prior to the Affordable Care Act.
Section 2(a)(2)(C)
Why it matters:This is standard legislative practice to ensure legal clarity and avoid unintended interactions with subsequent major legislation like the ACA, which significantly altered healthcare definitions and coverage parameters.
Case for: This clarification ensures that the eligibility criteria for breast and cervical cancer patients under this new mandate remain consistent with the original intent of the Breast and Cervical Cancer Treatment Program, preventing potential conflicts or ambiguities arising from broader ACA changes.
Case against: No specific case against this technical clarification is typically raised, as it serves to maintain consistency and avoid legal complications.
Estimated impact: Ensures consistent application of eligibility criteria for a specific group of Medicaid beneficiaries, impacting potentially millions of individuals over time by maintaining clear access pathways.